These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 27161848)

  • 21. Long-term Course of Depression Trajectories in Patients With COPD: A 3-Year Follow-up Analysis of the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints Cohort.
    Yohannes AM; Müllerová H; Hanania NA; Lavoie K; Tal-Singer R; Vestbo J; Rennard SI; Wouters EF
    Chest; 2016 Apr; 149(4):916-26. PubMed ID: 26836938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of body composition in COPD patients using multifrequency bioelectrical impedance analysis.
    de Blasio F; de Blasio F; Miracco Berlingieri G; Bianco A; La Greca M; Franssen FM; Scalfi L
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2419-2426. PubMed ID: 27757027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ectopic fat accumulation in patients with COPD: an ECLIPSE substudy.
    Martin M; Almeras N; Després JP; Coxson HO; Washko GR; Vivodtzev I; Wouters EF; Rutten E; Williams MC; Murchison JT; MacNee W; Sin DD; Maltais F
    Int J Chron Obstruct Pulmon Dis; 2017; 12():451-460. PubMed ID: 28203068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peripheral Artery Disease and Its Clinical Relevance in Patients with Chronic Obstructive Pulmonary Disease in the COPD and Systemic Consequences-Comorbidities Network Study.
    Houben-Wilke S; Jörres RA; Bals R; Franssen FM; Gläser S; Holle R; Karch A; Koch A; Magnussen H; Obst A; Schulz H; Spruit MA; Wacker ME; Welte T; Wouters EF; Vogelmeier C; Watz H
    Am J Respir Crit Care Med; 2017 Jan; 195(2):189-197. PubMed ID: 27532739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Implications of Sarcopenia on Decreased Bone Density in Men With COPD.
    Hwang JA; Kim YS; Leem AY; Park MS; Kim SK; Chang J; Jung JY
    Chest; 2017 May; 151(5):1018-1027. PubMed ID: 28012805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential Impact of Low Fat-Free Mass in People With COPD Based on BMI Classifications: Results From the COPD and Systemic Consequences-Comorbidities Network.
    Machado FVC; Vogelmeier CF; Jörres RA; Watz H; Bals R; Welte T; Spruit MA; Alter P; Franssen FME
    Chest; 2023 May; 163(5):1071-1083. PubMed ID: 36470414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: from sarcopenic obesity to cachexia.
    Biolo G; Cederholm T; Muscaritoli M
    Clin Nutr; 2014 Oct; 33(5):737-48. PubMed ID: 24785098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic kidney disease and high eGFR according to body composition phenotype in adults with normal BMI.
    Hyun YY; Lee KB; Rhee EJ; Park CY; Chang Y; Ryu S
    Nutr Metab Cardiovasc Dis; 2016 Dec; 26(12):1088-1095. PubMed ID: 27776918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between body composition, sarcopenia and pulmonary function in chronic obstructive pulmonary disease.
    Martínez-Luna N; Orea-Tejeda A; González-Islas D; Flores-Cisneros L; Keirns-Davis C; Sánchez-Santillán R; Pérez-García I; Gastelum-Ayala Y; Martínez-Vázquez V; Martínez-Reyna Ó
    BMC Pulm Med; 2022 Mar; 22(1):106. PubMed ID: 35346135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Associations of Sarcopenia and Sarcopenic Obesity With Metabolic Syndrome Considering Both Muscle Mass and Muscle Strength.
    Lee J; Hong YP; Shin HJ; Lee W
    J Prev Med Public Health; 2016 Jan; 49(1):35-44. PubMed ID: 26841883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic obstructive pulmonary disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes, prognostic markers, and functional status changes.
    Mok M; Nombela-Franco L; Dumont E; Urena M; DeLarochellière R; Doyle D; Villeneuve J; Côté M; Ribeiro HB; Allende R; Laflamme J; DeLarochellière H; Laflamme L; Amat-Santos I; Pibarot P; Maltais F; Rodés-Cabau J
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1072-84. PubMed ID: 24156967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Association of Depressive Symptoms With Rates of Acute Exacerbations in Patients With COPD: Results From a 3-year Longitudinal Follow-up of the ECLIPSE Cohort.
    Yohannes AM; Mülerová H; Lavoie K; Vestbo J; Rennard SI; Wouters E; Hanania NA
    J Am Med Dir Assoc; 2017 Nov; 18(11):955-959.e6. PubMed ID: 28733182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sarcopenia in Advanced COPD Affects Cardiometabolic Risk Reduction by Short-Term High-intensity Pulmonary Rehabilitation.
    Cebron Lipovec N; Schols AM; van den Borst B; Beijers RJ; Kosten T; Omersa D; Lainscak M
    J Am Med Dir Assoc; 2016 Sep; 17(9):814-20. PubMed ID: 27321867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined Exercise Training and Nutritional Interventions or Pharmacological Treatments to Improve Exercise Capacity and Body Composition in Chronic Obstructive Pulmonary Disease: A Narrative Review.
    Brauwers B; Machado FVC; Beijers RJHCG; Spruit MA; Franssen FME
    Nutrients; 2023 Dec; 15(24):. PubMed ID: 38140395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Whole-body resting and exercise-induced lipolysis in sarcopenic [corrected] patients with COPD.
    Franssen FM; Sauerwein HP; Rutten EP; Wouters EF; Schols AM
    Eur Respir J; 2008 Dec; 32(6):1466-71. PubMed ID: 18579550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of low body mass index on the development of chronic obstructive pulmonary disease and mortality.
    Park HJ; Cho JH; Kim HJ; Park JY; Lee HS; Byun MK
    J Intern Med; 2019 Nov; 286(5):573-582. PubMed ID: 31215064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dysregulated adipokine metabolism in chronic obstructive pulmonary disease.
    Breyer MK; Rutten EP; Locantore NW; Watkins ML; Miller BE; Wouters EF;
    Eur J Clin Invest; 2012 Sep; 42(9):983-91. PubMed ID: 22703238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adiposity influences airway wall thickness and the asthma phenotype of HIV-associated obstructive lung disease: a cross-sectional study.
    Barton JH; Ireland A; Fitzpatrick M; Kessinger C; Camp D; Weinman R; McMahon D; Leader JK; Holguin F; Wenzel SE; Morris A; Gingo MR
    BMC Pulm Med; 2016 Aug; 16(1):111. PubMed ID: 27488495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sarcopenia is associated with cardiovascular risk in men with COPD, independent of adiposity.
    Leem AY; Kim YS; Chung KS; Park MS; Kang YA; Park YM; Jung JY
    Respir Res; 2022 Jul; 23(1):185. PubMed ID: 35831851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Body composition and functional limitation in COPD.
    Eisner MD; Blanc PD; Sidney S; Yelin EH; Lathon PV; Katz PP; Tolstykh I; Ackerson L; Iribarren C
    Respir Res; 2007 Jan; 8(1):7. PubMed ID: 17261190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.